Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections

PURPOSE: High-dose methotrexate (HD-MTX) has been used to treat children with central nervous system tumors. Accumulation of MTX within pleural, peritoneal, or cardiac effusions has led to delayed excretion and increased risk of systemic toxicity. This retrospective study analyzed the association of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Chemother Pharmacol
Autors principals: Wright, Karen D., Panetta, John C., Onar-Thomas, Arzu, Reddick, Wilburn E., Patay, Zoltan, Qaddoumi, Ibrahim, Broniscer, Alberto, Robinson, Giles, Boop, Frederick A., Klimo, Paul, Ward, Deborah, Gajjar, Amar, Stewart, Clinton F.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282603/
https://ncbi.nlm.nih.gov/pubmed/25342291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-014-2614-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars